Please login to the form below

Not currently logged in
Email:
Password:

bacterial resistance

This page shows the latest bacterial resistance news and features for those working in and with pharma, biotech and healthcare.

Motif Bio preps US filing after antibiotic clears phase III

Motif Bio preps US filing after antibiotic clears phase III

resistance to other antibiotics, including ‘superbugs’such as methicillin resistant Staphylococcus aureus (MRSA). ... There is an urgent need for new antibiotics to counter the rising threat of antimicrobial resistance.

Latest news

  • Longitude Prize awards grants for antibiotic test development Longitude Prize awards grants for antibiotic test development

    Longitude Prize awards grants for antibiotic test development. Five UK teams among the winners seeking to tackle antimicrobial resistance. ... The Longitude committee, along with partner Innovate UK, hopes the fund will help halt the growth of bacterial

  • Merck starts pivotal trials of new antibiotic combination Merck starts pivotal trials of new antibiotic combination

    In some cases, carbapenems are the last-line therapy for MDR infections, but there has been a progressive increase in resistance to the class in bacterial families such as the Enterobacteriaceae, ... The first is comparing treatment with

  • CHMP backs AZ's 'superbug' antibiotic product CHMP backs AZ's 'superbug' antibiotic product

    The Committee for Medicinal Products for Human Use (CHMP) recommended approval of Zavicefta (ceftazidime/avibactam), which combines an established antibiotic with a new drug designed to overcome bacterial resistance. ... AZ notes that in Europe,

  • Ferring collaborates on novel IBD drug development Ferring collaborates on novel IBD drug development

    The use of bacteriophages has again come to the forefront of the field due to concerns of increased bacterial resistance due to overuse of antibiotics.

  • Antibiotics: pharma's Cinderella story Antibiotics: pharma's Cinderella story

    The early years. It has been 70 years since the advent of commercially available antibiotics to fight the tide of bacterial infection. ... In Europe, the Innovative Medicines Initiative has gained traction with the COMBACTE (Combatting Bacterial

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • The impending threat of antibiotic resistance The impending threat of antibiotic resistance

    The frequency of antibiotic resistance in a bacterial culture is in the order of one antibiotic resistant mutation in 100 million bacteria. ... Combining two existing antibiotics to see if they can overcome antibiotic resistance or.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics